Drug Repurposing to Identify Nilotinib as a Potential SARS-CoV-2 Main Protease Inhibitor: Insights from a Computational and In Vitro Study. - Souvik Banerjee; Shalini Yadav; Sourav Banerjee; Sayo O. Fakayode; Jyothi Parvathareddy; Walter Reichard; Surekha Surendranathan; Foyez Mahmud; Ryan Whatcott; Joshua Thammathong; Bernd Meibohm; Duane D. Miller; et al. (J. Chem. Inf. Model., 2021)